{"transactions":[{"id":2730114,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":97021,"kind":"organization","name":"Sphera Global Healthcare Management LP","position":1,"cik":"0001599854","reported_name":"Sphera Global Healthcare Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":97022,"kind":"organization","name":"Sphera Global Healthcare GP Ltd.","position":2,"cik":"0001599855","reported_name":"Sphera Global Healthcare GP Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":97310,"kind":"organization","name":"SPHERA FUNDS MANAGEMENT LTD.","position":3,"cik":"0001496201","reported_name":"SPHERA FUNDS MANAGEMENT LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-05-04T17:21:04.000Z","date":"2021-05-04","kind":"exercise","acquired":false,"shares":2713410,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On May 4, 2021, the Series B Preferred Stock automatically converted into Common Stock on a 8.6691-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 4, 2021, the Series B Preferred Stock automatically converted into Common Stock on a 8.6691-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 4, 2021, the Series B Preferred Stock automatically converted into Common Stock on a 8.6691-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Includes (a) 187,798 shares held by Sphera Global Healthcare Master Fund (the \"Healthcare Fund\") and (b) 125,199 shares held by Sphera\nBiotech Master Fund, LP (the \"Biotech Fund\" and, together with the Healthcare Fund, the \"Funds\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Sphera Global Healthcare Management LP is the investment manager for the Funds (the \"Management Company\").  The Management Company is managed, controlled and operated by its general partner Sphera Global Healthcare GP Ltd. (the \"General Partner\"), of which Sphera Funds Management Ltd. (\"SFML\") is the controlling shareholder. Each of the Management Company, the General Partner and SFML may be deemed the indirect beneficial owner of the reported securities for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":312997},"source":{"system":"sec-edgar","filing":"0001178913-21-001591","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1496201/000117891321001591/ownership.xml","form_type":"4"}},{"id":2730113,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":97021,"kind":"organization","name":"Sphera Global Healthcare Management LP","position":1,"cik":"0001599854","reported_name":"Sphera Global Healthcare Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":97022,"kind":"organization","name":"Sphera Global Healthcare GP Ltd.","position":2,"cik":"0001599855","reported_name":"Sphera Global Healthcare GP Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":97310,"kind":"organization","name":"SPHERA FUNDS MANAGEMENT LTD.","position":3,"cik":"0001496201","reported_name":"SPHERA FUNDS MANAGEMENT LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-04T17:21:04.000Z","date":"2021-05-04","kind":"purchase","acquired":true,"shares":475000,"price":16,"value":7600000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Includes (a) 300,000 shares held by the Healthcare Fund and (b) 175,000 shares held by the Biotech Fund."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes (a) 487,798 shares held by the Healthcare Fund and (b) 300,199 shares held by Biotech Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Sphera Global Healthcare Management LP is the investment manager for the Funds (the \"Management Company\").  The Management Company is managed, controlled and operated by its general partner Sphera Global Healthcare GP Ltd. (the \"General Partner\"), of which Sphera Funds Management Ltd. (\"SFML\") is the controlling shareholder. Each of the Management Company, the General Partner and SFML may be deemed the indirect beneficial owner of the reported securities for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended."}],"balance_after":787997,"source":{"system":"sec-edgar","filing":"0001178913-21-001591","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496201/000117891321001591/ownership.xml","form_type":"4"}},{"id":2730112,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":97021,"kind":"organization","name":"Sphera Global Healthcare Management LP","position":1,"cik":"0001599854","reported_name":"Sphera Global Healthcare Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":97022,"kind":"organization","name":"Sphera Global Healthcare GP Ltd.","position":2,"cik":"0001599855","reported_name":"Sphera Global Healthcare GP Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":97310,"kind":"organization","name":"SPHERA FUNDS MANAGEMENT LTD.","position":3,"cik":"0001496201","reported_name":"SPHERA FUNDS MANAGEMENT LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-04T17:21:04.000Z","date":"2021-05-04","kind":"exercise","acquired":true,"shares":312997,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes (a) 187,798 shares held by Sphera Global Healthcare Master Fund (the \"Healthcare Fund\") and (b) 125,199 shares held by Sphera\nBiotech Master Fund, LP (the \"Biotech Fund\" and, together with the Healthcare Fund, the \"Funds\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On May 4, 2021, the Series B Preferred Stock automatically converted into Common Stock on a 8.6691-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (a) 187,798 shares held by Sphera Global Healthcare Master Fund (the \"Healthcare Fund\") and (b) 125,199 shares held by Sphera\nBiotech Master Fund, LP (the \"Biotech Fund\" and, together with the Healthcare Fund, the \"Funds\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Sphera Global Healthcare Management LP is the investment manager for the Funds (the \"Management Company\").  The Management Company is managed, controlled and operated by its general partner Sphera Global Healthcare GP Ltd. (the \"General Partner\"), of which Sphera Funds Management Ltd. (\"SFML\") is the controlling shareholder. Each of the Management Company, the General Partner and SFML may be deemed the indirect beneficial owner of the reported securities for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended."}],"balance_after":312997,"source":{"system":"sec-edgar","filing":"0001178913-21-001591","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496201/000117891321001591/ownership.xml","form_type":"4"}}]}